Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro
about
Diarrheagenic Escherichia coliShiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function.Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infectionsThe bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1Investigation of encephalopathy caused by Shiga toxin 2c-producing Escherichia coli infection in mice.Induction by sphingomyelinase of shiga toxin receptor and shiga toxin 2 sensitivity in human microvascular endothelial cells.Shiga toxin 2 causes apoptosis in human brain microvascular endothelial cells via C/EBP homologous protein.p38 mitogen-activated protein kinase mediates lipopolysaccharide and tumor necrosis factor alpha induction of shiga toxin 2 sensitivity in human umbilical vein endothelial cellsMonocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndromeCharacterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model.Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality.Characterization of the cytokine immune response in children who have experienced an episode of typical hemolytic-uremic syndrome.Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro.Shiga toxin pathogenesis: kidney complications and renal failure.The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice.Effect of enterohaemorrhagic Escherichia coli O157:H7-specific enterohaemolysin on interleukin-1β production differs between human and mouse macrophages due to the different sensitivity of NLRP3 activation.Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin.Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitroApoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies.Advances in haemolytic uraemic syndrome.Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipidChemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharidesShiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinasesThe hemorrhagic coli pilus (HCP) of Escherichia coli O157:H7 is an inducer of proinflammatory cytokine secretion in intestinal epithelial cellsRole of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain.Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice.Role of nitric oxide in shiga toxin-2-induced premature delivery of dead fetuses in rats.Effect of shiga toxin and its subunits on cytokine induction in different cell lines.Localization of potential binding sites for the edema disease verotoxin (VT2e) in pigsShiga toxin 1 induces apoptosis in the human myelogenous leukemia cell line THP-1 by a caspase-8-dependent, tumor necrosis factor receptor-independent mechanism.Enhanced macrophage resistance to Pseudomonas exotoxin A is correlated with decreased expression of the low-density lipoprotein receptor-related protein.Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7.Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage.Local entrapment of interferon gamma in the recovery from Shigella dysenteriae type 1 infection.Enterohemorrhagic Escherichia coli specific enterohemolysin induced IL-1β in human macrophages and EHEC-induced IL-1β required activation of NLRP3 inflammasome.Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages.A translational murine model of sub-lethal intoxication with Shiga toxin 2 reveals novel ultrastructural findings in the brain striatum.Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue.
P2860
Q24533466-96E72818-B1B9-402B-B973-A44E62DBFABAQ24538771-DCED0D05-2EEF-4831-90A7-A773EE820562Q24550740-3F485FA6-FE7B-40B2-935F-DD884B4D62D7Q24563989-9FF88D26-B704-41B2-8FE3-E817EB67F067Q27334562-F36FB296-8F54-4A42-B25B-0923B8E0453EQ30310446-A74A371E-8601-4ADF-9AC1-7736F0CB9866Q30440723-4A813423-5051-4EFF-93EA-ACF65EAD4D66Q30441434-79092B68-4BB3-49BF-9DB1-91CA281504FEQ30442593-003E594D-B524-4474-A8A6-5E90BE4662AEQ33328717-7CE976D8-B6F2-4594-B1E9-575BAC6821CCQ33329124-5D4260DA-E7FD-4353-8B8D-4E6E88D79D6CQ33331011-DB055CBE-B252-45FB-833C-031AAC24226FQ33357487-C3BA3728-1365-4057-BC78-EA8096D54574Q33363208-619EDB81-2464-44D9-9624-B5563F1DF729Q33397541-C4AEE7B1-9F5A-43C6-A953-5CC72F3F6654Q33399096-6CEC09F4-FF3E-4063-958A-DFDAE5971077Q33419740-34536696-0554-4A7D-945F-FA06E6D4D47DQ33489940-1B30F5EE-7B68-4CB6-9A31-341A3217960AQ33493841-A8186FF5-3E70-4EB9-87C1-4CBAB5A54F84Q33501527-9935D019-CC13-4A24-8D8E-819539A0597CQ33502399-AB5A00C8-8FFF-4677-A042-5AEDEB10A919Q33503400-6E6553A0-9E97-4DBF-AC1B-61DE73AA3677Q33557728-45C920AB-0FCC-4E8E-A822-959D8A1C8021Q33599604-5F095907-7913-4492-8420-8F0D1518744FQ33658800-55BCB11B-DD66-48B1-A782-4C537F071AC5Q33748229-E711C469-0CDA-4B71-AE7C-038D53BAFBC4Q33752654-0BC47B79-082B-49E0-BE91-F4E36BF98941Q33785795-C1C7436A-96E9-4758-B7EB-3C4A31BFB2F9Q33849613-288F1E9E-D664-4866-B784-CFD6C1B49374Q33923342-0AA5875C-4189-43EE-B6C7-6CEB17250E44Q33946621-30019141-363E-472D-86B8-CA3FDE5A0995Q34002432-7594951D-84D0-42A6-A612-1F0145B7A648Q34003505-FFB4873E-E5C4-46C2-80AC-347760D782D8Q34119320-7F341AD0-0EA0-4641-87E1-017AF7B37222Q34409399-22251420-AA27-40D5-99E2-BDF2613BC4BAQ34500087-AD65562E-8BDC-4099-A4CD-7E8CD2771F23Q34534278-D29777E9-EA16-4D54-9FD5-55AF75486E56Q34545284-56790EED-DFA9-45D4-8E85-C36BECDA91ACQ34576977-A9F225FE-07A6-4D4D-BB48-9169E092DA59Q34889826-49A1FA3A-FE89-4E6F-9C3B-887E079E51AC
P2860
Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro
description
1991 nî lūn-bûn
@nan
1991 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Shiga toxin-associated hemolyt ...... lar endothelial cells in vitro
@ast
Shiga toxin-associated hemolyt ...... lar endothelial cells in vitro
@en
type
label
Shiga toxin-associated hemolyt ...... lar endothelial cells in vitro
@ast
Shiga toxin-associated hemolyt ...... lar endothelial cells in vitro
@en
prefLabel
Shiga toxin-associated hemolyt ...... lar endothelial cells in vitro
@ast
Shiga toxin-associated hemolyt ...... lar endothelial cells in vitro
@en
P2860
P921
P1476
Shiga toxin-associated hemolyt ...... lar endothelial cells in vitro
@en
P2093
P2860
P304
P407
P577
1991-11-01T00:00:00Z